预测药用植物和芳香植物的植物化学多样性 (MAPs) 跨生态气候区和Uttarakhand的高度使用通用添加剂模型
Deepti Tiwari1, Pushpa Kewlani1, Kailash S Gaira2
1G. B. Pant National Institute of Himalayan Environment, Kosi-Katarmal, Almora, Uttarakhand, 263 643, India.
Scientific reports
|July 5, 2023
概括
这项研究绘制了789种乌塔拉罕德州药用植物的植物化学多样性图,揭示了化学组和生物活性化合物的独特生态气候区域分布. 这些发现指导了对这些宝贵的喜马拉雅资源的保护和商业利用.
科学领域:
- 植物化学 植物化学
- 民族植物学 民族植物学
- 药用植物研究 药用植物研究
- 喜马拉雅的植物群
背景情况:
- 西喜马拉雅地区,特别是乌塔拉罕特邦,拥有丰富的药用植物多样性.
- 了解植物化学分布对于民族植物学和制药应用至关重要.
- 以前的研究还没有系统地绘制出乌塔拉罕德邦多样化的生态气候区的植物化学变异.
研究的目的:
- 系统地探索和分析乌塔拉罕德州药用植物的植物化学成分.
- 预测化学组和生物活性化合物在不同生态气候区和海拔地区的发生情况.
- 为保护工作提供信息,并为商业部门确定潜在的生物活性化合物.
主要方法:
- 对来自144个分类家族的789种药用植物进行了选.
- 基于化学组和生物活性化合物的植物化学成分分析.
- 通用添加模型 (GAM) 分析用于预测跨生态气候梯度的物种和化合物分布.
主要成果:
- 草药是占主导地位的生命形式 (58.86%).
- 化学组在热带,亚热带和温暖温带地区更为普遍.
- 生物活性化合物在阿尔卑斯山,亚阿尔卑斯山和低温温带的可能性更高.
- 具有活性化合物的物种发生率随着海拔的提高而下降 (p<0.01),而总活性化合物在1000米以上增加.
- 具有化学组的物种发生率随着海拔的提高而增加,但总化学组在1000米以上下降 (p<0.000).
结论:
- उत्तराखंड的药用植物中的植物化学分布受到生态气候因素和海拔高度的强烈影响.
- 该研究提供了一个预测框架,用于定位特定的植物化学物质,并优先考虑保护.
- 这些发现鼓励制药,营养品和化品行业对未充分利用的物种进行探索.
相关概念视频
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:27Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
01:09Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
01:29Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).